Advances and potential of regenerative medicine in pediatric nephrology.

Authors:
Slaats GG; Chen J; Levtchenko E; Verhaar MC; Arcolino FO.

Journal:
Pediatr Nephrol

Publication Year: 2023

DOI:
10.1007/s00467-023-06039-0

PMCID:
PMC10728238

PMID:
37400705

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Nephrol

Abbreviation: Pediatr Nephrol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A previously healthy 3-year-old female with hypertension, proteinuria, and hypercalciuria.
Liu T; Wang W; Liu Z and 4 more (2024) - Transparency Score: 3/6
Acute kidney injury in critically ill children with COVID-19 and MIS-C.
Özen H; Aslan AD; Balaban B and 10 more (2023) - Transparency Score: 2/6
Amniotic fluid content in children with kidney and urinary tract anomalies determines pre- and post…
Schulz AM; Lauten A; Lehmann T and 6 more (2023) - Transparency Score: 3/6
Antenatally detected urinary tract dilatation: long-term outcome.
Herthelius M. (2023) - Transparency Score: 3/6
A proposed framework for advancing acute kidney injury risk stratification and diagnosis in childre…
Fuhrman DY; Stanski NL; Krawczeski CD and 6 more (2023) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare no competing interests. Conflict of interest The authors declare no competing interests."

Evidence found in paper:

"Funding This work was funded by the Gravitation Program “Materials Driven Regeneration,” funded by the Netherlands Organization for Scientific Research (024.003.013) (to M.C.V.). The authors acknowledge the support of the partners of “Regenerative Medicine Crossing Borders” (RegMed XB). E. L. is supported by the ERC Consolidator grant 101045467 – NEOGRAFT."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025